User login
2017 MS Highlights: The Year in Review
Modern Day Laboring
Click here to read the supplement
Modern Day Laboring
Induction of Labor for Low-Risk Women: Is 39 the New 41?
Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA
Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care
Julian N. Robinson, MD; Sarah E. Little, MD
Click here to read the supplement
Modern Day Laboring
Induction of Labor for Low-Risk Women: Is 39 the New 41?
Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA
Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care
Julian N. Robinson, MD; Sarah E. Little, MD
Click here to read the supplement
Modern Day Laboring
Induction of Labor for Low-Risk Women: Is 39 the New 41?
Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA
Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care
Julian N. Robinson, MD; Sarah E. Little, MD
Highlights From the 7th Joint ECTRIMS‑ACTRIMS Meeting
Pediatric Vaccines & Infectious Diseases: Fall 2017
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
JFP PCEC Injectable Insulin Supplement
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Advantages of In-office Hysteroscopy in the Diagnosis of Abnormal Uterine Bleeding with Endosee
Click Here to Read the Supplement.
Topics include:
- The Endosee Office Procedure
- Patient Case Studies
- Advantages of Endosee Over Traditional Office Hysteroscopy
Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan
Click Here to Read the Supplement.
Click Here to Read the Supplement.
Topics include:
- The Endosee Office Procedure
- Patient Case Studies
- Advantages of Endosee Over Traditional Office Hysteroscopy
Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan
Click Here to Read the Supplement.
Click Here to Read the Supplement.
Topics include:
- The Endosee Office Procedure
- Patient Case Studies
- Advantages of Endosee Over Traditional Office Hysteroscopy
Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan
Click Here to Read the Supplement.
Abstracts Presented at the 2017 AVAHO Annual Meeting (Digital Edition)
Predicting Efficacy of AEDs in Children: Extrapolation of Data From Adult Clinical Trials
Click here to Read Supplement.
Topics include:
- The Pediatric Epilepsy Academic Consortium for Extrapolation (PEACE) initiative
- Ramifications for future pediatric AED approvals by the FDA
- Future PEACE initiatives
Authors:
O’NEILL D’CRUZ, MD, MBA, FAAN
Pediatric Epileptologist and Neurologist
OD Consulting and Neurological Services, PLLC
Chapel Hill, North Carolina
JOHN B. BODENSTEINER, MD
Consultant in Child and Adolescent Neurology and
Professor of Neurology and Pediatrics
Mayo Clinic and Mayo Medical School
Rochester, Minnesota
Click here to Read Supplement.
Topics include:
- The Pediatric Epilepsy Academic Consortium for Extrapolation (PEACE) initiative
- Ramifications for future pediatric AED approvals by the FDA
- Future PEACE initiatives
Authors:
O’NEILL D’CRUZ, MD, MBA, FAAN
Pediatric Epileptologist and Neurologist
OD Consulting and Neurological Services, PLLC
Chapel Hill, North Carolina
JOHN B. BODENSTEINER, MD
Consultant in Child and Adolescent Neurology and
Professor of Neurology and Pediatrics
Mayo Clinic and Mayo Medical School
Rochester, Minnesota
Click here to Read Supplement.
Topics include:
- The Pediatric Epilepsy Academic Consortium for Extrapolation (PEACE) initiative
- Ramifications for future pediatric AED approvals by the FDA
- Future PEACE initiatives
Authors:
O’NEILL D’CRUZ, MD, MBA, FAAN
Pediatric Epileptologist and Neurologist
OD Consulting and Neurological Services, PLLC
Chapel Hill, North Carolina
JOHN B. BODENSTEINER, MD
Consultant in Child and Adolescent Neurology and
Professor of Neurology and Pediatrics
Mayo Clinic and Mayo Medical School
Rochester, Minnesota
The Importance of Cord Blood and Cord Tissue Stem Cells: Today vs Tomorrow
Click Here to Read Supplement.
Topics include:
- Applications of cord blood stem cells
- Ongoing research with cord blood and cord tissue
- ASCT in autism spectrum disorder
- Patient education and counseling
- Banking options
- Science and education
Faculty/Faculty Disclosure:
Joel Weinthal, MD
Director of Pediatric Stem Cell Transplantation and Attending Physician
Texas Oncology Pediatrics
Medical Director, Apheresis and Stem Cell Laboratory
Medical City Dallas Hospital
Dallas, Texas
Dr. Weinthal reports that he is on the speakers’ bureau and advisory board, and a consultant, for CBR®, Cord Blood Registry®.
Click Here to Read the Supplement.
Click Here to Read Supplement.
Topics include:
- Applications of cord blood stem cells
- Ongoing research with cord blood and cord tissue
- ASCT in autism spectrum disorder
- Patient education and counseling
- Banking options
- Science and education
Faculty/Faculty Disclosure:
Joel Weinthal, MD
Director of Pediatric Stem Cell Transplantation and Attending Physician
Texas Oncology Pediatrics
Medical Director, Apheresis and Stem Cell Laboratory
Medical City Dallas Hospital
Dallas, Texas
Dr. Weinthal reports that he is on the speakers’ bureau and advisory board, and a consultant, for CBR®, Cord Blood Registry®.
Click Here to Read the Supplement.
Click Here to Read Supplement.
Topics include:
- Applications of cord blood stem cells
- Ongoing research with cord blood and cord tissue
- ASCT in autism spectrum disorder
- Patient education and counseling
- Banking options
- Science and education
Faculty/Faculty Disclosure:
Joel Weinthal, MD
Director of Pediatric Stem Cell Transplantation and Attending Physician
Texas Oncology Pediatrics
Medical Director, Apheresis and Stem Cell Laboratory
Medical City Dallas Hospital
Dallas, Texas
Dr. Weinthal reports that he is on the speakers’ bureau and advisory board, and a consultant, for CBR®, Cord Blood Registry®.
Click Here to Read the Supplement.
